858 Therapeutics is a biotechnology and drug discovery company based in San Diego, CA, specializing in the development of small molecule drugs targeting novel therapeutic targets in oncology and neuroscience. With a focus on emerging fields such as synthetic lethality, innate immunity, and RNA modulation, the company's experienced team is dedicated to discovering innovative therapeutics for the treatment of resistant cancers.
Founded by a veteran team with a successful track record in pharma and biotech drug discovery, 858 Therapeutics is headquartered in the biotech hub of San Diego and operates its lab operations in the same area, allowing for close collaboration with leading investigators and access to top scientific talent.
Generated from the website